title: Regulation of paf-acether receptor expression in human B cells.
abstract: Paf-acether (paf) is a phospholipid cytokine alloted with potent inflammatory and immunoregulatory properties. Recent reports indicated that in human B cell lines, paf modulated both early and late activation events. In our study, we showed that four of six human B cell lines specifically bound [3H]paf irrespective of the stage of differentiation, the presence of EBV genome or cell surface phenotype. Binding was saturated and fit a one receptor model with a dissociation constant ranging from 1 to 6 nM and a number of sites per cell ranging from approximately equal to 4000 in Rjc13 to approximately equal to 30,000 in Raji or IM9. In addition, our data indicate that 1) maximal expression occurred during the log phase growth; 2) paf itself (10-100 nM) or rIL-4 (100 U/ml) up-regulated by two- to threefold the number of paf binding sites without affecting the affinity. Finally, we found that activated normal B lymphocytes exhibited a higher capacity than resting B cells to incorporate and metabolize [3H]paf at 37 degrees C. Resting B lymphocytes lacked specific binding capacity for paf, yet specific paf receptors were induced upon stimulation via Staphylococcus aureus Cowan I or phorbol 12,13 dibutyrate plus ionomycin. These results suggest that B cell activation is a critical event for paf receptor expression and modulation.
authors.affiliation: Institut National de la Santé et de la Recherche Médicale U 131, Clamart, France.
authors.forename: C M
authors.initials: CM
authors.lastname: Nguer
authors.forename: O
authors.initials: O
authors.lastname: Pellegrini
authors.forename: P
authors.initials: P
authors.lastname: Galanaud
authors.forename: J
authors.initials: J
authors.lastname: Benveniste
authors.forename: Y
authors.initials: Y
authors.lastname: Thomas
authors.forename: Y
authors.initials: Y
authors.lastname: Richard
mesh_terms: D001402:B-Lymphocytes / Q000378:metabolism*; D002460:Cell Line; D019204:GTP-Binding Proteins / Q000502:physiology; D006801:Humans; D015847:Interleukin-4 / Q000494:pharmacology; D008213:Lymphocyte Activation; D010972:Platelet Activating Factor / Q000378:metabolism*; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface / Q000032:analysis*; D043562:Receptors, G-Protein-Coupled
chemical_list: D010972:Platelet Activating Factor; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; C039351:platelet activating factor receptor; D015847:Interleukin-4; D019204:GTP-Binding Proteins